São Paulo School of Advanced Science on Glycobiology (SPSAS-GLYC)
IMPORTANT NOTICE: Due to the COVID-19 pandemic, the SPSAS-GLYC will be postponed to 2021.
A possible new date will be announced soon.
Registrations are open until December 2020.
The São Paulo School of Advanced Science in Glycobiology (SPSAS-GLYC) will bring together 6 international and 6 national researchers who are reference in Glycobiology. The topics to be adressed have been selected for their relevance to academia and industry. The scientific program will cover:
1) biosynthesis and function of glycoconjugates;
2) glycan functions in cancer;
3) new methods for qualitative and quantitative analysis of glycoconjugates;
4) importance of glycan-binding proteins in pathological processes;
5) glycan-mediated immune system modulation;
6) glycobiology applied to the study of infectious diseases;
7) heparin and intracellular signaling;
8) chemical and enzymatic synthesis of glycoconjugates for disease treatment.
The SPSAS-GLYC will be funded by the São Paulo Research Foundation (FAPESP) which offers resources for the organization of short courses in advanced research in different areas of knowledge, contributing to students training and creating in the State of São Paulo a center of attraction for scientific talent.
Interested parties should apply at https://sites.usp.br/spsas-glyc/spsas-glyc/aplication/ until December 2020.
Applicants will be evaluated by the SPSAS-GLYC organizing committee who will notify all eligible participants by e-mail.
The applicants will be selected based on the letter of intent, abstract of the research project and the applicant CV.
Priority will be given to candidates currently enrolled in graduate programs (Masters/M.Sc. and Doctoral/Ph.D. courses) and developing a thesis in the field of Glycobiology.
The applicant’s country of origin will also be taken into consideration, in order to include participants from all continents.
Instituto de Ciências Biomédicas – ICB/USP
Field of Knowledge
To be defined
2020-02-06 to 2020-12-01
Glycobiology, glycans, biosynthesis, pathological processes
Find out about the program at: https://sites.usp.br/spsas-glyc/program/
Adriane Todeschini – Federal University of Rio de Janeiro, Brazil
Giuseppe Palmisano – Biomedical Sciences Institute, University of São Paulo, Brazil
Maria Cristina Roque Antunes Barreira – Ribeirão Preto Medical School, University of São Paulo, Brazil
Roger Chammas – Medical School, University of São Paulo, Brazil
Walter Colli – Institute of Chemistry, University of São Paulo, Brazil
Ajit Varki – Glycobiology Research and Training Center, University of California, USA
Carolyn Bertozzi – School of Humanities and Sciences, Stanford University, USA
Marcelo Lima – School of Life Sciences, Keele University, UK
Mike Ferguson – School of Life Sciences, University of Dundee, UK
Morten Thaysen Andersen – Department of Molecular Sciences, Macquarie University, Australia
Richard Cummings – National Center for Functional Glycomics, Harvard Medical School, USA
ScienMag - March 12, 2020
Agência FAPESP - March 11, 2020